Skip to main content
OpenTrials
Completed

NCT Number: NCT00401648

Effect of Brivaracetam in Photosensitive Epileptic Subjects

to assess the effect of brivaracetam on the photoparoxysmal EEG response in photosensitive epileptic subjects

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Epilepsy Brain Diseases Central Nervous System Diseases Nervous System Diseases

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Marseille, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • epileptic subjects with generalized PPR

Exclusion criteria

  • more than 2 concomitant antiepileptic drugs

Treatment and study plan

Brivaracetam

Drug

Primary outcomes

  1. Identify lowest single oral dose producing maximal decrease or suppression of intermittent photic stimulation (IPS)photoparoxysmal response (PPR) in photosensitive epileptic subjects pre-dose

  2. post placebo during 24h and post brivaracetam for up to 72 h

Secondary outcomes

  1. Assess relationship between plasma concentrations and changes in photosensitivity frequency range, time of onset and duration of suppressing effect

  2. Safety

Sponsors and collaborators

Lead sponsor

UCB Pharma

Industry

Registry information

Official study title

A Placebo-controlled, Single-blind, Multi-center Study to Explore the Photoparoxysmal Response in Photosensitive Epileptic Subjects After One Single Oral Dose of Brivaracetam in Capsules.

Important dates

Study start
2002
Primary completion
2003
Study completion
2003
First posted
Nov 20, 2006
Registry last updated
Dec 1, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.